National trends in dihydropyrimidine deficiency testing before fluoropyrimidine chemotherapy.
536 Background: In 2025, the Food and Drug Administration and National Comprehensive Cancer Centers Network updated their guidelines to recommend screening for genetic dihydropyrimidine dehydrogenase deficiency (DPYD) prior to administration of fluoropyrimidine chemotherapies (5-fluorouracil and capecitabine)....